EGFR and cancer: Epidermal growth factor receptor (EGFR) and its ligand, epidermal growth factor (EGF), are overexpressed in many malignancies, including cancers of the head and neck, breast, kidney, lung, colon, ovary, prostate, brain and spine, pancreas, and bladder [1].